No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

MedSafety Solutions Earns EU-MDR Certification

Meets New, Strengthened Requirements for Safety and Performance

Editor: What To Know

  • This achievement is a major milestone for MedSafety Solutions in its ongoing mission to provide hospital pharmacies in the European market with the products and expertise they need to perform safely and effectively.
  • As a result of this assessment, conducted by audit and technical review, BSI determined that MedSafety Solutions met the needed requirements and issued its EU Quality Management System Certificate.
  • Comes as a result of strict performance assessments of MedSafety Solution’s quality management systems and an evaluation of general safety and performance indicators.

MedSafety Solutions today announced that it has received the European Union Medical Devices Regulations (EU-MDR) certification as of September 9, 2021.

This achievement is a major milestone for MedSafety Solutions in its ongoing mission to provide hospital pharmacies in the European market with the products and expertise they need to perform safely and effectively.

The British Standards Institution BSI completed their conformity assessment to include quality management systems as well as general safety and performance standards. As a result of this assessment, conducted by audit and technical review, BSI determined that MedSafety Solutions met the needed requirements and issued its EU Quality Management System Certificate.

“Receiving this certification demonstrates our commitment to compliance with new regulations and to meeting customers’ needs safely and predictably,” says Steve van Engen, founder and CEO at MedSafety Solutions. “Additionally, receiving this certification ahead of many other companies will serve as a distinct competitive advantage.”

This news takes on significant importance in that the new certification:

  • Is significantly more stringent than the Medical Devices Directive (MDD), the previous regulatory framework
  • Comes as a result of strict performance assessments of MedSafety Solution’s quality management systems and an evaluation of general safety and performance indicators
  • Enables MedSafety Solutions to advance its position in the European market

To learn more about the EU-MDR certification, click here to contact us.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy